Meet the Novartis Foundation Board of Trustees.
Portraite of Joerg Reinhardt, Ph.D
Chairman of the Board of Directors, Novartis
Joerg Reinhardt, Ph.D.

Joerg Reinhardt, Ph.D., is Chairman of the Board of Trustees of the Novartis Foundation. He is also Chairman of the Board of Directors of Novartis.

Portrait of Ann Aerts, M.D.
Head of the Novartis Foundation
Ann Aerts, M.D.

Ann Aerts has been leading the Novartis Foundation since 2013. Her and her team's work focus on improving urban heart health and narrowing health inequities through data- and digital-led population health approaches.

Portrait of Prof. Dr. Jo Ivey Boufford
Clinical Professor of Global Public Health, New York University President of the International Society for Urban Health
Prof. Dr. Jo Ivey Boufford

Dr. Jo Ivey Boufford is an expert in urban health, disease prevention, healthy aging, health promotion and health disparities.

Portrait of Lutz Hegemann, M.D., Ph.D.
President, Global Health & Sustainability of Novartis
Lutz Hegemann, M.D., Ph.D.

Lutz Hegemann leads the Novartis Global Health unit and is responsible for integrating environmental, social and governance (ESG) matters into the core of the company’s business, with a special emphasis on innovation and access.

Portrait of John Kahan
Vice President and Chief Data Analytics Officer Emeritus at Microsoft, Founder and President of the Aaron Matthew SIDS Research Foundation of Seattle Children’s
John Kahan

John is a proven data-driven leader with nearly four decades of data science, worldwide business, and technology transformation experience across Microsoft and IBM.

Portrait of Prof. Peter Piot, M.D.
Special Advisor on COVID-19 to the President of the European Commission
Prof. Peter Piot, M.D.

Peter Piot MD PhD is the Handa Professor of Global Health and former Director of the London School of Hygiene & Tropical Medicine.

Portrait of Andreas von Planta, Ph.D.
Andreas von Planta, Ph.D.

Andreas von Planta is a leading expert in corporate governance, corporate law and stock exchange regulation. He advises boards of public companies on corporate governance matters and is a sought-after speaker and writer on these topics.